because ca2+ antagonists may alter glucose homeostasis by blocking calcium entry into pancreatic beta-cells , this risk was evaluated for nicardipine , a new dihydropyridine derivative with vasodilatory effects .
C0028005
nicardipine
C0012315
dihydropyridine